Fundamental dimension Equity attribute | CVRLeader $10.50▲+4.79% Cap $10.14MP/E -4.2x QuantScore43/100 | CETYPeer $0.925▲+3.93% Cap $11.25MP/E -0.8x QuantScore23/100 | CLWTPeer $1.35▲+2.27% Cap $10.01MP/E 65.5x QuantScore32/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
47/100 |
44/100 |
47/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 33/100 | 26/100 |
Health Piotroski, Altman Z, leverage & liquidity | 64/100 | 16/100 | 51/100 |
Growth Revenue / earnings growth & margins | 30/100 | 0/100 | 4/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -4.2x | -0.8x | 65.5x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -7.3x | -3.9x | -22.1x |
Price / Sales | 0.4x | 4.9x | 0.8x |
Price / Free Cash Flow | -7.1x | -1.4x | — |
PEG ratio | 0.07 | 0.07 | -0.84 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 0 / 9 | 3 / 9 |
Altman Z-Score | 3.41 (Safe) | -3.67 (Distress) | 2.49 (Grey) |
Total debt / equity | 0.03 | 0.65 | 0.02 |
Quick ratio | 1.6x | 0.9x | 1.9x |
Interest coverage | — | -0.9x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.3% | -10.8% | -13.8% |
Net income growth YoY | +80.7% | -49.6% | -78.6% |
Gross margin (TTM) | 11.0% | -15.4% | 27.7% |
Operating margin (FY) | -5.5% | -118.4% | -1.8% |
FCF margin (FY) | -5.6% | -367.1% | -8.3% |
5. Trailing price performancePrice change over period |
1M return | +2.4% | -7.5% | -1.5% |
3M return | +6.1% | +0.6% | -14.0% |
6M return | -11.2% | +16.3% | +8.0% |
Year to date | -24.5% | +27.6% | +12.5% |
1Y return | +9.9% | -62.4% | +8.9% |
3Y return | -40.5% | -95.7% | -4.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-14.17 -235.0% premium | $-1.03 -211.9% premium | $1.30 -3.6% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |